Ohcanbohtosat - Lauren E. Strelec
- Čájehuvvo 1 - 3 / 3
-
1
R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis Dahkki Nirav N. Shah, Anikó Szabó, Scott F. Huntington, Narendranath Epperla, Nishitha Reddy, Siddhartha Ganguly, Julie M. Vose, Cynthia Obiozor, Fahad Faruqi, Alexandra E. Kovach, Luciano J. Costa, Ana C. Xavier, Ryan Okal, Abraham S. Kanate, Nilanjan Ghosh, Mohamed A. Kharfan‐Dabaja, Lauren E. Strelec, Mehdi Hamadani, Timothy S. Fenske, Oscar Calzada, Jonathon B. Cohen, Julio C. Chávez, Jakub Svoboda
Almmustuhtton 2017Artigo -
2
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience Dahkki Anthony R. Mato, Chadi Nabhan, Paul M. Barr, Chaitra S. Ujjani, Brian T. Hill, Nicole Lamanna, Alan P Skarbnik, Christina Howlett, Jeffrey J. Pu, Alison R. Sehgal, Lauren E. Strelec, Alexandra Vandegrift, Danielle M. Fitzpatrick, Clive S. Zent, Tatyana Feldman, André Goy, David F. Claxton, Spencer Henick Bachow, Gurbakhash Kaur, Jakub Svoboda, Sunita D. Nasta, David L. Porter, Daniel J. Landsburg, Stephen J. Schuster, Bruce D. Cheson, Pavel Kiselev, Andrew M. Evens
Almmustuhtton 2016Artigo -
3
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas Dahkki Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita D. Nasta, Sarah Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O’Hara, Sameh Gaballa, Lauren E. Strelec, Elise A. Chong, Sheryl Mitnick, Terease S. Waite, Cara M King, Hatcher J. Ballard, Matthew R. Youngman, James N. Gerson, John P. Plastaras, Amit Maity, Agata M. Bogusz, Stacy Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan S. Lim, Marco Ruella, Stephen J. Schuster
Almmustuhtton 2020Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Internal medicine
Medicine
Oncology
Chemotherapy
Cyclophosphamide
Gastroenterology
Lymphoma
Prednisone
Regimen
Rituximab
Surgery
Vincristine
Astronomy
B-cell lymphoma
Brentuximab vedotin
CD30
CHOP
Chronic lymphocytic leukemia
Discontinuation
Epoch (astronomy)
Etoposide
Ibrutinib
Idelalisib
Leukemia
Physics
Stars
Toxicity